Symptoms are a poor indication of severity of reflux in Barrett's oesophagus

Aims: Patients with Barrett's oesophagus have increased acid and duodenogastric reflux and impaired motility compared with non‐Barrett's patients with reflux disease. Impaired sensitivity to acid infusion and distension have also been described, but the relationship of this visceral response to symptoms is unclear. A symptom index was used to compare Barrett's and non‐Barrett's patients with reflux. Methods: Patients with reflux (DeMeester score above 14) were studied with 24‐h pH monitoring and manometry. An event marker recorded symptom events. An event was positive if it corresponded to a period greater than 10 s within 2 min either side of the drop in pH. The symptom index was calculated as the number of symptoms with pH less than 4/total number of symptoms × 100.Acid score Symptom index (%) Motility disturbance (%)Non‐Barrett's 41 (17 − 137) 52 (0 − 100) 22 Barrett's 70 (12 − 194) 0 (0 − 100) * 56 †Values are median (range). * P < 0.01 † P < 0.05 (Wilcoxon and χ 2 tests)Results: Eighteen patients with Barrett's oesophagus were compared with 58 non‐Barrett's patients with significant reflux. Conclusions: Patients with Barrett's oesophagus have a low symptom index compared with non‐Barrett's patients with reflux disease. This occurs despite a near 100 per cent increase in acid exposure in the Barrett's group. Symptoms are thus no guide to the severity of reflux in patients with Barrett's oesophagus. Proof of efficacy of therapeutic modalities may need physiological rather than symptom‐based confirmation. © 2000 British Journal of Surgery Society Ltd